EASL and the WHO have combined to create their first joint webinar on COVID-19 and the liver, broadcast on 14 May 2020. A panel of leading international experts in hepatology and virology reviewed the latest information on the COVID-19 pandemic, the WHO response, and the impact on the care of people with liver disease and viral hepatitis, both from a clinical and public health perspective. The panel also heard directly from front-line clinicians and programme managers from different countries on their experiences in the COVID-19 national response, and in managing the impact on hepatitis services during the current crisis.
Targeted audience:
- General Practitioners
- Hepatologists
- Health care professionals
- Programme managers